Todd Watanabe
Chief Executive Officer chez ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : 11 M $ au 31/03/2024
Postes actifs de Todd Watanabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 01/01/2016 | - |
| Chief Executive Officer | 01/04/2017 | - | |
| President | 01/01/2016 | - | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Director/Board Member | 23/06/2021 | - |
Historique de carrière de Todd Watanabe
Anciens postes connus de Todd Watanabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Kanan Therapeutics, Inc. | Chief Operating Officer | 01/12/2015 | 01/02/2018 |
| Founder | 01/12/2015 | 01/02/2018 | |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01/10/2013 | 01/11/2015 |
Formation de Todd Watanabe
| Georgetown University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
| Kanan Therapeutics, Inc. |
- Bourse
- Insiders
- Todd Watanabe
- Expérience
